Seeing Is Believing
Currently out of the existing stock ratings of Alex Thompson, 43 are a BUY (71.67%), 17 are a HOLD (28.33%).
Analyst Alex Thompson, currently employed at STIFEL, carries an average stock price target met ratio of 46.8% that have a potential upside of 46.36% achieved within 129 days.
Alex Thompson’s has documented 120 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TVTX, Travere Therapeutics at 12-Sep-2025.
Analyst best performing recommendations are on DICE (DICE MOLECULES HOLDINGS LLC).
The best stock recommendation documented was for DICE (DICE MOLECULES HOLDINGS LLC) at 9/6/2022. The price target of $37 was fulfilled within 35 days with a profit of $18.05 (95.25%) receiving and performance score of 27.21.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$56
2 years 3 months 9 days ago
(26-Jun-2023)
0/1 (0%)
$27.35 (95.46%)
Hold
$48
$0.45 (0.95%)
$60
2 years 3 months 14 days ago
(21-Jun-2023)
1/3 (33.33%)
$1.41 (3.03%)
85
Hold
$48
$0.45 (0.95%)
$38
2 years 3 months 15 days ago
(20-Jun-2023)
1/2 (50%)
$1.56 (3.36%)
27
Hold
$48
$0.45 (0.95%)
$71
2 years 3 months 15 days ago
(20-Jun-2023)
0/2 (0%)
$1.56 (3.36%)
Buy
$77
$29.45 (61.93%)
$46
2 years 11 months 24 days ago
(11-Oct-2022)
1/2 (50%)
$37 (92.50%)
617
Which stock is Alex Thompson is most bullish on?
What Year was the first public recommendation made by Alex Thompson?